Severe COVID-19-associated myocarditis with cardiogenic shock – management with assist devices – a case report & review

BMC Anesthesiology

Case Report

Stephanie Noone¹  Armin N. Flinspach¹  Kai Zacharowski¹  Florian J. Raimann¹  Michael Sonntagbauer¹  Stephan Fichtlscherer² 

[1] Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany;Division of Cardiology, Department of Internal Medicine III, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany;

关键词: Myocarditis;    SARS-COV-2;    Extracorporeal membrane oxygenation;    Critical care;    Heart failure;    Impella;   

DOI  :  10.1186/s12871-022-01890-4

 received in 2022-07-05, accepted in 2022-10-26,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundPrimary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.Case presentationWe report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.ConclusionsThe majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

40249_2022_1045_Article_IEq23.gif

40249_2022_1045_Article_IEq14.gif